Case 17-2024: A 45-Year-Old Woman with Metastatic Breast Cancer
A 45-year-old woman was evaluated in the oncology clinic of the hospital because of metastatic triple-negative breast cancer that had progressed despite chemotherapy. Management...
Intention to Treat: Treating Obesity in Kids — ITT Episode 31
In the face of a growing childhood obesity epidemic, some parents and clinicians are turning to new tools such as GLP-1 receptor agonists. This...
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker
A highly pathogenic avian influenza A(H5N1) virus infection was identified in a dairy farm worker in Texas. This pathogen has been reported in multiple...
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
More patients treated with isatuximab, bortezomib, lenalidomide, and dexamethasone had improved progression-free survival and had a complete or better response than those treated with...
